NSF designs and implements robust solutions related to the complex development, approval, marketing and manufacturing of FDA-regulated products throughout the total product lifecycle.
Three key indicators are at the heart of our most successful, positive and sustainable remediation projects:
Your company's culture, organisation and support systems directly impact how teams execute remediation activities. Remediation projects succeed when a company aligns its organisation with a common vision to meet regulatory requirements and support business strategy.
NSF offers planning and strategic services that help companies align business goals with regulatory requirements. From corrective action planning to quality system remediation, NSF supports your team's remediation efforts.
Clear and consistent communication ensures that members of your organisation have a common understanding of why sustainable organisational improvements are required. It includes detailed plans and strategies for remediation project activities, as well as expectations for directly affected personnel and support staff. Communications must be planned, measured, consistent and managed to ensure organisation-wide support for your efforts.
In addition to planning and strategy support, NSF provides the following communication services:
- Medical devices FDA Form 483 correspondence
- Warning letter responses
- Regulatory agency major nonconformity responses
- Field safety notices (FSNs)
- Field safety corrective actions (FSCAs)
- Recall letters and correspondence
- Patient and user communications
Establishing a quality system that meets your regulatory and business needs is challenging enough. In most instances, it requires the input of third-party experts. Strengthening relationships between team members and your overall organisation spurs organisational change. As team members collaborate toward a common goal, they share openly, discuss solutions and build consensus.
To support your company as you collaboratively identify and address
gaps, NSF conducts baseline assessments, due diligence assessments,
third-party internal audits, FDA mock regulatory readiness inspections
and QSIT audits.
Your success is our success. When you use the right expertise to develop the right solutions, your organisation stays on the road to sustainable quality.
Ready to Begin the Process?
Contact us with questions or to receive a quote.
NSF Health Sciences Journal: Time to Rethink - Issue 47, 2020
NSF’s Remediation Resources
Insights and Expertise
Case Study: A Tale of Two Pharmaceutical Remediation Projects